Funding opportunities to address sexually transmitted and blood-borne infections (STBBI)
We are currently accepting Letters of Intent (LOI) submissions under the HIV and Hepatitis C Community Action Fund (CAF) and Harm Reduction Fund (HRF). The deadline to submit an LOI is January 29, 2021 at 3 pm EST. We will only accept LOIs until the submission deadline. Only those applications submitted through the online portal will be accepted for consideration.
Supporting the community response to sexually transmitted and blood-borne infections (STBBI) in Canada
Government of Canada efforts to address STBBI in Canada are guided by the Pan-Canadian Framework for Action on STBBI and the Government of Canada Five Year Action Plan on STBBI.
HIV and Hepatitis C Community Action Fund (CAF):
The Public Health Agency of Canada (PHAC) invests $26.4 million annually to support time-limited projects across Canada to address HIV, hepatitis C and other sexually transmitted infections (e.g. chlamydia, gonorrhea, syphilis) through the CAF.
Organizations can apply for a maximum of 5 years of project funding.
Harm Reduction Fund:
PHAC invests $7 million annually to support time-limited projects across Canada that will help reduce HIV and hepatitis C among people who share injection and inhalation drug-use equipment through the HRF.
Organizations can apply for 3 or 5 years of project funding for a maximum of $250,000 per year. PHAC may accept requests for larger investments depending on the scope and scale of the project.
The CAF and HRF seek to ensure that:
- community-based efforts reach key populations, including people unaware of their HIV or hepatitis C status, and link them to testing, prevention, treatment and care
- communities design and implement evidence-based front-line projects to prevent new and reoccurring infections
- high impact interventions are brought to scale so that more people benefit from them
- community-based efforts reduce stigma toward populations disproportionally affected by STBBI, including people living with HIV or hepatitis C
Report a problem or mistake on this page
- Date modified: